galantamine oor Fins
galantamine
en
(organic chemistry) An alkaloid, obtained synthetically or from various plants, used for the treatment of mild to moderate Alzheimer's disease and various memory impairments.
Vertalings in die woordeboek Engels - Fins
Galantamiini
en
chemical compound
fi
kemiallinen yhdiste
Geskatte vertalings
Vertoon algoritmies gegenereerde vertalings
voorbeelde
Advanced filtering
Voorbeelde moet herlaai word.
In 1987, Synaptech, the defendant in the main proceedings, filed an application for a galantamine patent at the European Patent Office, claiming the use of galantamine for the treatment of Alzheimer’s disease.
Voiko kansaa syyttää?EurLex-2 EurLex-2
Galantamine
Se on mielettömän siistiäeurlex eurlex
12 In 1963, the competent Austrian authorities granted to Waldheim, in accordance with the Austrian law in force at the time, marketing authorisation for the medicinal product galantamine, under the brand name ‘Nivalin,’ for the treatment of poliomyelitis.
Ensin heititte minut putkaanEurLex-2 EurLex-2
In a clinical study in young healthy subjects no relevant effect of memantine on the pharmacokinetics of galantamine was observed
Yksityiskoulu ei tarkoita, ettetkö olisi tyhmäEMEA0.3 EMEA0.3
It is apparent from the order for reference that, following discussion of the specific case of galantamine, the CMD(h) published a statement on its website (part of the website of Heads of the EU Medicines Agencies) that a medicinal product can be used as a reference medicinal product for the purpose of the data exclusivity period as of the date of accession of the Member State to the EU only if the medicinal product is in compliance with the Community acquis.
artiklassa tarkoitettu luetteloEurLex-2 EurLex-2
17 On 14 December 2005, in the context of a decentralised procedure pursuant to Article 28(1) of Directive 2001/83, Generics submitted an application to the Licensing Authority for marketing authorisation for a generic of galantamine for the British market.
Se on sinun ongelmasiEurLex-2 EurLex-2
21 In Germany, galantamine was already on the market in the 1960s under the same trade mark.
Maalia ei hyväksyttyEurLex-2 EurLex-2
2 The reference has been made in proceedings between Generics (UK) Ltd (‘Generics’) and Synaptech Inc. (‘Synaptech’) concerning the supplementary protection certificate (‘SPC’) granted for the product ‘Galantamine or acid addition salts thereof’ (‘galantamine’).
Tarkastus on tehtävä seuraavassa esitettyjen vaihtoehtojen tai vastaavien toimenpiteiden perusteellaEurLex-2 EurLex-2
Under the German Law of 1976, galantamine could remain on the German market as a product deemed to be authorised as a medicinal product under a ‘fictitious’ authorisation.
En, ei mitään sellaistaEurLex-2 EurLex-2
Galantamine (INN)
laadun ja turvallisuuden takaamiseksiEurlex2019 Eurlex2019
Meanwhile, as a result of cooperation agreements with Waldheim, in 1999 Janssen-Cilag AB submitted a full application to the competent Swedish authority (the Swedish Medicinal Products Agency, ‘the Swedish MPA’), pursuant to Article 4 of Directive 65/65 (now Article 8 of Directive 2001/83), for marketing authorisation for galantamine, under the brand name ‘Reminyl’, for the treatment of Alzheimer’s disease (in particular, an Alzheimer-type dementia).
Näiden toimenpiteiden ansiosta sääntöjenvastaisten alusten ei enää pitäisi päästä Euroopan aluevesilleEurLex-2 EurLex-2
Galantamine and donepezil do not show a clinically relevant effect on the pharmacokinetics of risperidone and on the active antipsychotic fraction
Hei, kultaseniEMEA0.3 EMEA0.3
Moreover, such a restriction is not warranted by the protection of public health, because galantamine has been used within Europe for decades and within the EEA since 1994.
Kivettynyttä sellaistaEurLex-2 EurLex-2
(‘Synaptech’) concerning the determination of the date of expiry of an SPC owned by Synaptech and granted by the United Kingdom Patent Office for the product ‘Galantamine or acid addition salts thereof’ (‘the galantamine SPC’).
Olen ruusunnuppusi ja kaipaan puutarhurin hyväilyä.EurLex-2 EurLex-2
23 In 1997 Janssen-Cilag took over distribution of Nivalin in Austria and, in 1999, filed an application in Sweden for a marketing authorisation for the use of galantamine in a medicinal product to treat Alzheimer’s disease under the brand name Reminyl (‘Reminyl’).
Suunniteltu päättymisaikaEurLex-2 EurLex-2
Fourthly, Generics maintains that it follows from the case-law that the refusal to issue a marketing authorisation for a medicinal product for which the active ingredient is imported from another Member State (in this case, Belgium, where Generics sources galantamine hydrobromide), while that product was issued a marketing authorisation in both the Member State of export (Belgium) and the Member State of import (the United Kingdom), constitutes a restriction on the free movement of goods which is contrary to Article 28 EC.
Heitin poisEurLex-2 EurLex-2
20 In 1963 a marketing authorisation was issued in Austria, under the 1947 medicines regulations, for galantamine to be used as a medicinal product in the treatment of poliomyelitis under the trade mark Nivalin (‘Nivalin’).
Annosta voi olla tarpeen säätää potilailla, joilla on munuaisongelmia tai tiettyjä sivuvaikutuksiaEurLex-2 EurLex-2
On 14 December 2005, in the context of a decentralised procedure pursuant to Article 28(1) of Directive 2001/83, Generics (UK) Ltd (‘Generics’), a British distributor of medicinal products, submitted an application for marketing authorisation for a generic form of galantamine to the Licensing Authority, the competent national body for granting authorisations in the United Kingdom, which was designated as the reference Member State.
Jos käytät enemmän Enbreliä kuin Sinun pitäisiEurLex-2 EurLex-2
It is apparent, inter alia, from that analysis that an authorisation such as that obtained in Germany for galantamine, granted by the competent authorities of a Member State pursuant to the transitional arrangements introduced by Article 24 of Directive 65/65, in conjunction with Article 39 of Directive 75/319, and as amended by Article 37 of that directive, on the basis of a marketing authorisation granted prior to the transposition of Directive 65/65 into the legal order of that Member State, may be regarded as the first marketing authorisation in the Community for the purposes of Article 13 of the regulation.
Miksen?Mitä he tekevät?EurLex-2 EurLex-2
85 sinne gevind in 7 ms. Hulle kom uit baie bronne en word nie nagegaan nie.